BMJ Hosted (Intended for Healthcare Professionals)

This resource provides information on the management of patients with adult ADHD.Contains promotional content for UK Healthcare Professionals.Click here for Prescribing Information and Adverse Event Reporting.Job code: C-APROM/UK/ELVA/0062Date of Preparation: March 2021Initiated, developed and funded by Takeda Pharmaceuticals Limited.

This resource provides information on the management of patients with hereditary angioedema.Initiated and funded by Takeda UK Limited.
Click here for Prescribing Information and Adverse Event Reporting
Job code: C-APROM/GB/TAKH/0013Date of preparation: December 2021

A survey of 710 people with rosacea and 554 doctors has revealed valuable insights on the invisible impact of a visible disease for the patients and the community. It is time to fight back against stereotypes and talk openly about rosacea burden.

This resource, which contains promotional information developed and funded by Pfizer Ltd, is intended for UK healthcare professionals only.
For Genotropin (somatropin, rbe) Prescribing Information and Adverse Event Reporting, click here.

PP-GEN-GBR-1016Date of preparation: May 2021

This site is intended for UK Healthcare Professionals OnlyThe following site contains Promotional Information on Fasenra ▼ (benralizumab) GB-33421 | DOP: December 2021

This content is promotional and has been developed, organised and funded by Lilly.Intended for UK healthcare professionals only.Click here for prescribing information and adverse events reporting.PP-IX-GB-1582 October 2021
Taltz® and Lilly are registered trademarks of Eli Lilly and Company© 2021 Eli Lilly and Company. All rights reserved.

This resource provides information on the management of patients with primary immunodeficiency.Initiated and funded by Takeda UK Limited.
Click here for Prescribing Information and Adverse Event Reporting.
Job code:C-APROM/UK/IG/0027Date of preparation: June 2021

Click here to learn how you can overcome this wall of silence.
Intended for Healthcare Professionals only. This content is developed, organized and funded by Eli Lilly and Company.
Job code: GM-21534PP-MG-GB-0261 July 2021.

Watch Dr Hal Martin discuss the patient reported outcomes of people taking Biktarvy.
This video is created and funded by Gilead Sciences Ltd and is intended for healthcare professionals only.
Click here for prescribing information and adverse event reporting

UK-HIV-2021-03-0049 | July 2021

This resource, which contains promotional information developed and funded by Pfizer Ltd, is intended for UK healthcare professionals only.For Cresemba (isavuconazole), Zavicefta (ceftazidime and avibactam), and Zinforo (ceftaroline fosamil) Prescribing Information and Adverse Event reporting, click here.PP-AIP-GBR-0887. January 2022

Testosterone deficiency -
a hidden problem?
Find out how testosterone deficiency
- Can affect testicular cancer patients
- Could be a consideration in elderly male patients with unexplained anaemia

This page has been developed and funded by Besins Healthcare (UK) Ltd, is intended for UK healthcare professionals only and contains promotional content.
TES/2021/057 | June 2021

This resource provides further information about Taltz from clinical trial data to real world evidence, as well as downloadable resources.
This promotional content has been developed, organised and funded by Eli Lilly and Company and is intended for UK healthcare professionals only.
Click here for Prescribing Information and Adverse Events reporting.
PP-IX-GB-1710 January 2022

This webpage contains promotional material developed and funded by Celgene, a Bristol Myers Squibb Company, and is intended for UK Healthcare Professionals only. Prescribing Information and Adverse Event Reporting can be found at the bottom of the hosted content page2010-GB-2100110. DOP: November 2021

Promotional content developed by Accord-UK LtdIntended for UK Healthcare Professionals onlyClick here for prescribing and adverse event reporting informationUK-03040 November 2021

For UK and IE healthcare professionals only. The Iron Deficiency Anaemia Resource is designed for healthcare professionals who manage patients with chronic kidney disease, congestive heart failure, inflammatory bowel disease or those listed for major elective surgery.
Click here for Prescribing Information
Job code: UKIE-MONF-1221-00002Date of preparation: January 2022

Date of preparation: November 2021MAT-IE-2100533(v2.0)

This resource provides information on the rare genetic disease, MPS I.Intended for UK healthcare professionals only.A link to the Prescribing Information and Adverse Event Reporting can be found at the top of the hosted content page.MAT-GB-2104718(v1.0) October 2021

Please click here for adverse event reporting and prescribing information (included at the top of the page)Trulicity is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise

• as monotherapy when metformin is considered inappropriate due to intolerance or contraindications
• in addition to other medicinal products for the treatment of diabetes

Rubraca is indicated as monotherapy for the maintenance treatment of adult patients with platinum-sensitive relapsed high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) to platinum-based chemotherapy¹.This information is intended for UK healthcare professionals only. Prescribing information and adverse event reporting information can be found here.MAT-RUCA-UK-0387Date of preparation: January 2022